Which closed-end funds own Biomarin Pharmaceutical?
17 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $8.6M. Security type: debt security. Country: United States. CUSIP 09061GAL5 · ISIN US09061GAL59.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| IGI Western Asset Investment Grade Opportunity Trust | Investment Grade | 0.19% | $198K | 200,000 par | $105M | 7.7% discount | May 29, 2026 |
| ISD PGIM High Yield Bond Fund | High Yield | 0.09% | $405K | 415,000 par | $452M | 11.0% discount | Jul 31, 2026 |
| HYT BlackRock Corporate High Yield Fund | High Yield | 0.08% | $2.1M | 2,126,000 par | $2.5B | 11.3% discount | Jun 30, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | 0.08% | $195K | 200,000 par | $259M | 15.9% discount | Jul 31, 2026 |
| GHY PGIM Global High Yield Fund | High Yield | 0.08% | $473K | 485,000 par | $629M | 12.3% discount | Jul 31, 2026 |
| CHY Calamos Convertible & High Income Fund | Convertible Securities | 0.07% | $1.1M | 1,100,000 par | $1.5B | 0.3% premium | Jul 31, 2026 |
| CHI Calamos Convertible Opportunities & Income Fund | Convertible Securities | 0.07% | $918K | 940,000 par | $1.4B | 4.5% premium | Jul 31, 2026 |
| BLW BlackRock Ltd Duration Income Trust | Taxable Bonds | 0.06% | $334K | 340,000 par | $532M | 9.0% discount | Jun 30, 2026 |
| AWF AllianceBernstein Global High Income Fund | High Yield | 0.05% | $491K | 500,000 par | $982M | 13.1% discount | Jun 30, 2026 |
| JMM Nuveen Multi-Market Income Fund | Taxable Bonds | 0.05% | $39.3K | 40,000 par | $81.4M | 9.6% discount | Jun 30, 2026 |
| BTZ BlackRock Credit Allocation Income Trust | Taxable Bonds | 0.04% | $422K | 430,000 par | $1.2B | 10.2% discount | Jun 30, 2026 |
| DSU BlackRock Debt Strategies Fund | Taxable Bonds | 0.03% | $196K | 200,000 par | $750M | 6.9% discount | Jun 30, 2026 |
| CSQ Calamos Strategic Total Return Fund | Multi-Asset | 0.03% | $1.3M | 1,300,000 par | $4.9B | 9.4% discount | Jul 31, 2026 |
| CCD Calamos Dynamic Convertible & Income Fund | Convertible Securities | 0.03% | $244K | 250,000 par | $939M | 6.7% premium | Jul 31, 2026 |
| CHW Calamos Global Dynamic Income Fund | Taxable Bonds | 0.02% | $205K | 210,000 par | $836M | 9.5% discount | Jul 31, 2026 |
| VGI Virtus Global Multi-Sector Income Fund | Multi-Asset | 0.00% | $4.9K | 5,000 par | $129M | 10.8% discount | May 29, 2026 |
| ZTR Virtus Total Return Fund | Multi-Asset | 0.00% | $9.9K | 10,000 par | $533M | 10.4% discount | May 29, 2026 |
17 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: BIOMARIN PHARMACEUTICAL INC; BioMarin Pharmaceutical Inc.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Biomarin Pharmaceutical Inc | loan | 11 |
| Biomarin Pharmaceutical Inc | common equity | 7 |
Issuer-level search for “BIOMARIN PHARMACEUTICAL” → · Compare two funds’ portfolios →